NKTR
Nektar Therapeutics
60.50$
+2.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -145.8% | – | – | – | – | – | – | |
| – | -0.6% | +19.4% | -4.0% | -26.3% | +21.0% | +7.8% | -0.3% | -7.9% | -40.0% | -43.8% | -202.2% | |
| – | +15.6% | +31.4% | +41.6% | +140.6% | +13.3% | -5.5% | +0.4% | -39.5% | -41.8% | -35.3% | -41.5% | |
| – | +13.2% | -24.2% | +82.1% | +215.7% | +16.5% | -14.2% | +58.1% | -57.8% | – | – | – | |
| – | – | – | -574.4% | – | – | -22.9% | -238.1% | – | -4,124.4% | – | – | |
| – | +12.2% | -42.9% | +51.4% | +47.2% | +84.6% | -72.4% | +106.5% | -62.1% | -84.8% | +69.7% | -88.4% | |
| – | -61.8% | +474.8% | -65.0% | +4,689.9% | – | +139.8% | -59.1% | +80.4% | -61.9% | +2.2% | -100.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -80.3% | +550.7% | -71.6% | +1,331.3% | -97.3% | +0.2% | +42.1% | – | – | – | -100.0% | |
| – | – | -106.0% | -13.7% | +4,772.3% | +0.0% | +0.0% | -100.0% | – | – | – | – | |
| – | -14.5% | +55.7% | -73.3% | +1,466.4% | -97.3% | -444.1% | – | -95.8% | -98.0% | +140,293.3% | +328.7% | |
| – | – | -90.6% | -1,448.4% | – | -151.8% | – | -269.3% | – | -184.0% | – | -424.6% | |
| – | – | – | – | – | -150.4% | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.